Metabolic & Mitochondrial Research
A category page built for PepDaddy’s NAD+, MOTS-c, SS-31, Epitalon, and related metabolic or cellular-energy discussion pages.
How this category should read
This page should sound more like a research briefing than a sales page. Users in this cluster tend to be interested in aging, mitochondrial performance, metabolic signalling, and cellular-energy language. The page should help them understand where PepDaddy’s catalogue fits into those topics without making claims the evidence cannot support.
Use a simple split: NAD-related context, mitochondrial-derived peptide context, mitochondria-targeted peptide context, and healthy-aging support context. Then route to the relevant product pages.
Suggested comparison table
| Product family | Best use on page |
|---|---|
| NAD+ | Anchor the broad aging and metabolic context section |
| MOTS-c | Use as the strongest mitochondria-derived peptide comparison page |
| SS-31 / Elamipretide-style positioning | Present as mitochondria-targeted discussion with careful evidence framing |
| Epitalon | Place inside healthy-aging / longevity support reading path |
Next-click architecture
The strongest internal links on this page are: NAD+ 1000mg, MOTS-c 10mg, SS-31 50mg, Epitalon 10mg, and the COA page. Add one FAQ block that answers storage, lab-testing, and category-fit questions in plain English.
Keep the copy tight. One overview section, one comparison table, four short product family summaries, one limitations section, and one CTA band is enough.
Recommended CTA block
This category should route visitors into the most relevant product family, then give them the lab-testing page as the trust-building backup path.
Citations
- 1. PepDaddy WordPress export showing Metabolic category and NAD+, MOTS-c, SS-31, Epitalon pages
- 2. NAD+ as a central metabolic hub regulating the hallmarks of aging | PubMed — https://pubmed.ncbi.nlm.nih.gov/41812700/
- 3. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis | PubMed — https://pubmed.ncbi.nlm.nih.gov/25738459/
- 4. The correlation between mitochondrial derived peptide and metabolic states: systematic review | PubMed — https://pubmed.ncbi.nlm.nih.gov/39160573/
- 5. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy | PubMed — https://pubmed.ncbi.nlm.nih.gov/29500292/
- 6. Targeting mitochondrial dysfunction with elamipretide | PubMed — https://pubmed.ncbi.nlm.nih.gov/35037146/
Leave a Reply